Piramal Pharma Invests $80 Million to Expand Sterile Injectable Facility in Kentucky
Introduction:
Piramal Pharma Solutions (PPS) is investing $80M to expand its Lexington, Kentucky facility. This site specializes in sterile injectable drug products, including compounding, liquid filling, and lyophilization. The expansion will support PPS's ADCelerate™ program for antibody-drug conjugates and enhance capacity to meet growing market demand.
Features:
This site expansion will introduce an additional 24,000 square feet of manufacturing space, a modern laboratory, and cutting-edge equipment to enhance product scalability for clients.
Notable upgrades include a new filling line, two large-scale lyophilizers, a specialized capping machine, and an external vial washer.
Currently operating at peak capacity, the site produces 104 product batches annually the capacity is expected to exceed 240 batches per year.
With advancements in the efficiency and effectiveness of injectable treatments, more patients will gain access to these innovative therapies.
The expansion of the sterile injectables facility will be completed by 2028.
Specifications:
| Name | Piramal Pharma Solutions |
| Type | Expansion |
| Budget | $80 Million |
| Year | 2028 |
